Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.

Chovatiya R, Armstrong A, Kircik L, Puig L, Kirchhof MG, Torres T, Binamer Y, Duarte G, Akmaz B, Dossenbach M, Gallo G, Yang C, Seminario-Vidal L, Ding Y, Silverberg JI.

Open source

DOI
10.1007/s13555-025-01620-x
Published
2025-12-20
Container
Dermatol Ther (Heidelb)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-025-01620-x,
  title = {Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.},
  author = {Chovatiya R and  Armstrong A and  Kircik L and  Puig L and  Kirchhof MG and  Torres T and  Binamer Y and  Duarte G and  Akmaz B and  Dossenbach M and  Gallo G and  Yang C and  Seminario-Vidal L and  Ding Y and  Silverberg JI.},
  year = {2026},
  journal = {Dermatol Ther (Heidelb)},
  doi = {10.1007/s13555-025-01620-x},
  url = {https://doi.org/10.1007/s13555-025-01620-x}
}

RIS

TY  - JOUR
TI  - Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.
AU  - Chovatiya R
AU  -  Armstrong A
AU  -  Kircik L
AU  -  Puig L
AU  -  Kirchhof MG
AU  -  Torres T
AU  -  Binamer Y
AU  -  Duarte G
AU  -  Akmaz B
AU  -  Dossenbach M
AU  -  Gallo G
AU  -  Yang C
AU  -  Seminario-Vidal L
AU  -  Ding Y
AU  -  Silverberg JI.
PY  - 2026
JO  - Dermatol Ther (Heidelb)
DO  - 10.1007/s13555-025-01620-x
UR  - https://doi.org/10.1007/s13555-025-01620-x
ER  - 

APA

R, C., A, A., L, K., L, P., MG, K., T, T., Y, B., G, D., B, A., M, D., G, G., C, Y., L, S., Y, D., & JI., S. (2026). Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.. Dermatol Ther (Heidelb). https://doi.org/10.1007/s13555-025-01620-x

Source records